Prioritizing resources to advance avexitide in hyperinsulinemic hypoglycemia indicationsActive discussions underway with potential partners to advance late-stage virology programsReduction in workforce executed to align with focus on avexitide; ext.
15.12.2022 - Eiger BioPharmaceuticals, Inc. (“Eiger” or “the company”) (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis delta virus (HDV) and other serious diseases, and its Board of . Seite 1
Eiger BioPharmaceuticals Announces Leadership Change streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Glomerulonephritis Treatment Market by drug class (Corticosteroids, Diuretic, Alkylating Agents) and by distribution channel (Hospital Pharmacies, E-commer
Glomerulonephritis Treatment Market by drug class (Corticosteroids, Diuretic, Alkylating Agents) and by distribution channel (Hospital Pharmacies, E-commer